Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-16 · accession 0001708138-21-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-17 | 2021-08-16 | REGN | Bassler Bonnie L | Dir | M - OptEx | $376.69 | +1,219 | 2,110 | +137% | +$459.2K |
| D | 2021-08-17 | 2021-08-16 | REGN | Bassler Bonnie L | Dir | S - Sale+OE | $630.00 | -1,219 | 891 | -58% | -$768.0K |
| D | 2021-08-17 | 2021-08-16 | REGN | Bassler Bonnie L | Dir | M - OptEx | $0.00 | -1,219 | 1,219 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-16 | M | A | 1,219 | $376.69 | 2,110 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-16 | S | D | 1,219 | $630.00 | 891 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-16 | M | D | 1,219 | $0.00 | 1,219 | D | $376.69 · — to 2027-01-03 | 1,219 Common Stock | (F2) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |